Status:
COMPLETED
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
Lead Sponsor:
Eastern Cooperative Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18-120 years
Brief Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors predict how well patients will respond to treatment. PURPOSE: This research study is studying biomar...
Detailed Description
OBJECTIVES: * To investigate the association between biomarkers (HPV tumor status and ERCC1 expression) and clinical outcomes in a population of patients with recurrent or metastatic head and neck ca...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Tissue specimens from patients with recurrent or metastatic head and neck cancer treated on ECOG-E1395 and ECOG-E3301
- Stage III, IV, or recurrent disease
- Squamous cell disease
- Any of the following diagnoses:
- Lip and oral cavity
- Oropharynx
- Hypopharynx
- Larynx
- Paranasal sinus and nasal cavity
- Squamous neck cancer
- Salivary gland
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
December 22 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 22 2012
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT01487733
Start Date
December 22 2011
End Date
January 22 2012
Last Update
May 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.